Kopran Share Price
Kopran Share Price Today
As of 5 Jul 2026, Kopran share price is ₹193.31. The stock opened at ₹186.10, compared to its previous close of ₹187.84. During today's trading session, Kopran share price moved in the range of ₹186.10 to ₹195.00, with an average price of ₹190.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹107.00 and a high of ₹219.00. On the performance front, Kopran share price has increased by 27.11% over the last six months and is up 6.30% on a year-on-year basis.
Kopran Returns Calculator
Kopran Shareholder Returns
Kopran Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Kopran Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹629.60 | ₹614.59 | ₹550.99 | ₹477.52 |
| Other Income | ₹3.98 | ₹14.61 | ₹3.07 | ₹10.60 |
| Total Revenue | ₹633.59 | ₹629.20 | ₹554.05 | ₹488.13 |
| Total Expenses | ₹581.64 | ₹561.66 | ₹517.99 | ₹406.35 |
| Profit Before Tax | ₹51.95 | ₹67.54 | ₹36.07 | ₹81.78 |
| Tax | ₹13.40 | ₹16.59 | ₹8.83 | ₹20.75 |
| Profit After Tax | ₹38.55 | ₹50.96 | ₹27.23 | ₹61.03 |
| EPS - Basic | ₹7.99 | ₹10.57 | ₹5.65 | ₹13.77 |
| EPS - Diluted | ₹7.99 | ₹10.57 | ₹5.65 | ₹13.77 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹51.95 | ₹67.54 | ₹36.07 | ₹81.78 |
| Income before WC changes | ₹76.75 | ₹88.50 | ₹52.36 | ₹95.60 |
| Change in Assets | -₹39.13 | -₹37.47 | -₹73.13 | -₹89.48 |
| Change in Liabilities | ₹17.57 | ₹6.55 | ₹67.58 | -₹21.33 |
| Change in WC | -₹21.56 | -₹30.91 | -₹5.55 | -₹110.81 |
| Cash flow from Operations | ₹41.94 | ₹43.26 | ₹34.02 | -₹33.48 |
| Cash flow from Investing | -₹56.43 | -₹43.55 | -₹12.65 | -₹84.42 |
| Cash flow from Financing | ₹25.87 | ₹0.99 | -₹19.84 | ₹122.82 |
| Total Cash Flow | ₹11.38 | ₹0.69 | ₹1.53 | ₹4.93 |
| Cash (Start of the year) | ₹8.09 | ₹7.40 | ₹5.87 | ₹0.94 |
| Cash (End of the year) | ₹19.47 | ₹8.09 | ₹7.40 | ₹5.87 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹334.26 | ₹289.22 | ₹250.63 | ₹196.01 |
| Current Assets | ₹509.75 | ₹454.03 | ₹399.07 | ₹414.87 |
| Total Assets | ₹844.01 | ₹743.25 | ₹649.70 | ₹610.89 |
| Current Liabilities | ₹288.97 | ₹218.53 | ₹176.97 | ₹151.59 |
| Net Current Asset | ₹220.78 | ₹235.50 | ₹222.10 | ₹263.29 |
| Non-Current Liabilities | ₹36.70 | ₹33.47 | ₹33.48 | ₹33.13 |
| Equity Capital | ₹518.35 | ₹491.25 | ₹439.25 | ₹426.17 |
| Total Equity & Liabilities | ₹844.01 | ₹743.25 | ₹649.70 | ₹610.89 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹271.01 | ₹337.46 | ₹273.09 | ₹204.52 |
| Other Income | ₹5.90 | ₹16.71 | ₹16.09 | ₹8.03 |
| Total Revenue | ₹276.91 | ₹354.17 | ₹289.18 | ₹212.55 |
| Total Expenses | ₹241.12 | ₹309.65 | ₹252.27 | ₹196.38 |
| Profit Before Tax | ₹35.79 | ₹44.52 | ₹36.92 | ₹16.16 |
| Tax | ₹8.94 | ₹9.88 | ₹5.66 | ₹4.42 |
| Profit After Tax | ₹26.86 | ₹34.64 | ₹31.25 | ₹11.74 |
| EPS - Basic | ₹5.57 | ₹7.18 | ₹6.48 | ₹2.65 |
| EPS - Diluted | ₹5.57 | ₹7.17 | ₹6.48 | ₹2.65 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹35.79 | ₹44.52 | ₹36.92 | ₹16.16 |
| Income before WC changes | ₹42.38 | ₹47.20 | ₹27.87 | ₹20.33 |
| Change in Assets | -₹5.26 | ₹8.36 | -₹39.24 | -₹41.63 |
| Change in Liabilities | -₹3.73 | -₹10.77 | ₹34.55 | -₹12.90 |
| Change in WC | -₹8.99 | -₹2.41 | -₹4.68 | -₹54.53 |
| Cash flow from Operations | ₹23.30 | ₹34.96 | ₹16.87 | -₹37.80 |
| Cash flow from Investing | -₹15.41 | -₹6.27 | ₹10.05 | -₹100.26 |
| Cash flow from Financing | ₹5.64 | -₹24.08 | -₹26.13 | ₹137.99 |
| Total Cash Flow | ₹13.53 | ₹4.61 | ₹0.79 | -₹0.07 |
| Cash (Start of the year) | ₹5.65 | ₹1.04 | ₹0.25 | ₹0.32 |
| Cash (End of the year) | ₹19.18 | ₹5.65 | ₹1.04 | ₹0.25 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹337.44 | ₹323.17 | ₹315.54 | ₹312.81 |
| Current Assets | ₹209.05 | ₹187.70 | ₹190.41 | ₹151.31 |
| Total Assets | ₹546.48 | ₹510.88 | ₹505.95 | ₹464.12 |
| Current Liabilities | ₹103.33 | ₹84.54 | ₹100.88 | ₹76.25 |
| Net Current Asset | ₹105.72 | ₹103.16 | ₹89.53 | ₹75.06 |
| Non-Current Liabilities | ₹11.72 | ₹9.47 | ₹9.48 | ₹9.14 |
| Equity Capital | ₹431.44 | ₹416.87 | ₹395.59 | ₹378.72 |
| Total Equity & Liabilities | ₹546.48 | ₹510.88 | ₹505.95 | ₹464.12 |
About Kopran
Kopran Limited is an India-based pharmaceutical company. The Company is primarily engaged in the business of manufacturing of formulation (finished dosage form) and active pharmaceutical ingredients (API). Its formulations product categories include penicillin-based finished oral dosage forms and non-penicillin-based finished oral dosage forms. The Company's penicillin-based finished oral dosage forms include amoxycillin, ampicillin, cloxacillin, amoxy clauv, flucloxacillin, and phenoxy methyl penicillin. Its non-penicillin-based finished oral dosage forms include macrolides, cardiovascular, anti-helmentics, antihistamine, anti-diabetic, pain management, gastroenterology, and respiratory. It has a portfolio, producing over 100 dosage forms. These include tablets, capsules, dry powder, suspension and injectables. Its subsidiary, Kopran Research Laboratories Ltd, manufactures a range of APIs, including Atenolol and Sterile Carbapenems.
Kopran Financial Highlights
- Revenue: Kopran reported revenue of ₹681.77 crore in FY26 vs ₹633.58 crore in FY25. It showed an increase of 7.61% on a yearly basis.
- Operating Profit: Kopran reported an operating profit of ₹34.36 crore in FY26 vs ₹51.95 crore in FY25. It showed a decrease of 33.86% on a year-on-year basis.
- Net Profit: Kopran reported a net profit of ₹25.73 crore in FY26 vs ₹38.55 crore in FY25. It showed a decrease of 33.26% on a yearly basis.
Kopran Quarterly Result Highlights
- Kopran reported revenue of ₹234.11 crore in Mar 2026, compared with ₹194.35 crore in Dec 2025, representing an increase of 20.46% on a quarter-on-quarter (QoQ) basis.
- Kopran reported an operating profit of ₹25.35 crore in Mar 2026, compared with ₹10.74 crore in Dec 2025, representing an increase of 136.03% on a quarter-on-quarter (QoQ) basis.
- Kopran reported a profit of ₹18.87 crore in Mar 2026, compared with ₹9.34 crore in Dec 2025, reflecting an increase of 102.03% on a QoQ basis.
- The earnings per share (EPS) of Kopran stood at ₹7.99 during Mar 2026.
Similar Stocks
FAQs on Kopran Share Price
What is Kopran share price today?
Kopran share price is ₹193.31 as on 03 Jul, 2026, 15:59 IST.
How has the Kopran share price performed in the past?
In the last 1 year, Kopran delivered a return of 6.30%. The Kopran share price hit a high of ₹219.00 and low of ₹107.00.
How much is the Mutual Fund shareholding in Kopran shares?
The Mutual Fund Shareholding in Kopran was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Kopran shares ?
The 52-week high and low of Kopran share is ₹219.00 and ₹107.00 as of 03 Jul, 2026.
What is the market cap of Kopran?
The market capitalisation of Kopran is ₹902.70 Crores as on 03 Jul, 2026.
What are the stock symbols of Kopran?
The stock symbol of Kopran is KOPRAN on the NSE, 524280 on the BSE, and the ISIN is INE082A01010.
What was yesterday's closing price of Kopran shares ?
Kopran shares closed yesterday at ₹187.84 on NSE & ₹186.95 on BSE
How to buy Kopran shares?
To buy Kopran shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Kopran shares on Holidays?
No, shares of Kopran or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Kopran shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Kopran?
The PE and PB ratio of Kopran is 35.08 and 1.7 respectively, as on 03 Jul, 2026, 15:59 IST.